Home » Topics » BioWorld

BioWorld
RSS

BIOCHEMICAL CHANGES IN ALZHEIMER'S

March 2, 1992

LTIZ FILES SECONDARY OFFERING

Feb. 28, 1992

SKIN SUBSTITUTE SCORES WELL IN TESTS

Feb. 28, 1992

CORTECH SPIN-OFF RAISES $8.5 MILLION

Feb. 28, 1992

COR BEGINS PHASE II TRIALS OF ANGINA DRUG

Feb. 28, 1992

EPIGEN PACT FOR CARCINOMA ANTIGEN

Feb. 28, 1992

BLECH COMPANIES AGREE TO $50M MERGER

Feb. 28, 1992

SCID MICE ENGRAFT HUMAN STEM CELLS

Feb. 28, 1992

INVESTORS BUY HEAVILY ON ARASINE RESULTS

Feb. 28, 1992

LIDAK ISSUES PREFERRED AND WARRANTS

Feb. 27, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...